JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) PS Ratio: 0.84 (As of Jul. 24, 2026) — 57% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:JSP JSP Pharmaceutical Manufacturing (Thailand) PCL BKK:JSP
82 GF Score
Price ฿1.75
GF Value ฿3.17
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is JSP Pharmaceutical Manufacturing (Thailand) PCL PS Ratio?

JSP Pharmaceutical Manufacturing (Thailand) PCL BKK:JSP 82 PS Ratio is 0.84 as of Jul. 24, 2026, which is 57% below its 10-year median of 1.94. GuruFocus rates BKK:JSP with a GF Score™ of 82/100 and a GF Value™ of ฿3.17 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 1,940 Consumer Packaged Goods companies, JSP Pharmaceutical Manufacturing (Thailand) PCL ranks better than 50.93% on this metric.

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, JSP Pharmaceutical Manufacturing (Thailand) PCL's share price is ฿1.75. JSP Pharmaceutical Manufacturing (Thailand) PCL's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ฿2.09. Hence, JSP Pharmaceutical Manufacturing (Thailand) PCL's PS Ratio for today is 0.84.

The historical rank and industry rank for JSP Pharmaceutical Manufacturing (Thailand) PCL's PS Ratio or its related term are showing as below:

BKK:JSP' s PS Ratio Range Over the Past 10 Years
Min: 0.76   Med: 1.94   Max: 17.58
Current: 0.84

During the past 7 years, JSP Pharmaceutical Manufacturing (Thailand) PCL's highest PS Ratio was 17.58. The lowest was 0.76. And the median was 1.94.

BKK:JSP's PS Ratio is ranked better than
50.93% of 1940 companies
in the Consumer Packaged Goods industry
Industry Median: 0.85 vs BKK:JSP: 0.84

JSP Pharmaceutical Manufacturing (Thailand) PCL's Revenue per Sharefor the three months ended in Mar. 2026 was ฿0.44. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ฿2.09.

During the past 12 months, the average Revenue per Share Growth Rate of JSP Pharmaceutical Manufacturing (Thailand) PCL was 10.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was 30.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was 15.70% per year.

During the past 7 years, JSP Pharmaceutical Manufacturing (Thailand) PCL's highest 3-Year average Revenue per Share Growth Rate was 30.70% per year. The lowest was 3.10% per year. And the median was 10.20% per year.

Back to Basics: PS Ratio


JSP Pharmaceutical Manufacturing (Thailand) PCL  (BKK:JSP) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


JSP Pharmaceutical Manufacturing (Thailand) PCL PS Ratio Related Terms


JSP Pharmaceutical Manufacturing (Thailand) PCL PS Ratio Historical Data

* Premium members only.

The historical data trend for JSP Pharmaceutical Manufacturing (Thailand) PCL's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JSP Pharmaceutical Manufacturing (Thailand) PCL PS Ratio Chart

JSP Pharmaceutical Manufacturing (Thailand) PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PS Ratio
Get a 7-Day Free Trial 6.31 3.79 2.10 1.16 0.89

JSP Pharmaceutical Manufacturing (Thailand) PCL Quarterly Data
Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 0.83 0.89 0.89 0.93

BKK:JSP vs KHC, GIS: PS Ratio Comparison

For the Packaged Foods subindustry, JSP Pharmaceutical Manufacturing (Thailand) PCL's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JSP Pharmaceutical Manufacturing (Thailand) PCL PS Ratio vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, JSP Pharmaceutical Manufacturing (Thailand) PCL's PS Ratio distribution charts can be found below:

* The bar in red indicates where JSP Pharmaceutical Manufacturing (Thailand) PCL's PS Ratio falls into.


BKK:JSP
82GF Score
JSP Pharmaceutical Manufacturing (Thailand) PCL BKK:JSP
PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JSP Pharmaceutical Manufacturing (Thailand) PCL PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

JSP Pharmaceutical Manufacturing (Thailand) PCL's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=1.75/2.093
=0.84

JSP Pharmaceutical Manufacturing (Thailand) PCL's Share Price of today is ฿1.75.
JSP Pharmaceutical Manufacturing (Thailand) PCL's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿2.09.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.

Frequently Asked Questions Learn more about PS Ratio →
What does a PS Ratio of 0.84 mean?
JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) has a PS Ratio of 0.84 as of Jul. 24, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on JSP Pharmaceutical Manufacturing (Thailand) PCL and its competitors. This is 57% below median its historical median of 1.94. Over the past decade, JSP Pharmaceutical Manufacturing (Thailand) PCL's PS Ratio has ranged from 0.76 to 17.58. According to the industry distribution chart, JSP Pharmaceutical Manufacturing (Thailand) PCL ranks #952 out of 1940 companies in the Consumer Packaged Goods industry, placing it in the top 49.1%.
Is JSP Pharmaceutical Manufacturing (Thailand) PCL's PS Ratio too high?
JSP Pharmaceutical Manufacturing (Thailand) PCL's current PS Ratio of 0.84 is 57% below median its 10-year median of 1.94. Over the past 10 years, this metric has ranged from a low of 0.76 to a high of 17.58. The Consumer Packaged Goods industry median PS Ratio is 0.85. JSP Pharmaceutical Manufacturing (Thailand) PCL's value of 0.84 is 1.2% below this industry median. Based on the distribution chart, JSP Pharmaceutical Manufacturing (Thailand) PCL ranks #952 out of 1940 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, JSP Pharmaceutical Manufacturing (Thailand) PCL has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JSP Pharmaceutical Manufacturing (Thailand) PCL's PS Ratio compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, JSP Pharmaceutical Manufacturing (Thailand) PCL ranks #952 out of 1940 companies for PS Ratio. This puts JSP Pharmaceutical Manufacturing (Thailand) PCL in the upper half of its industry. The industry median PS Ratio is 0.85. JSP Pharmaceutical Manufacturing (Thailand) PCL's value of 0.84 is 1.2% below this benchmark. Historically, JSP Pharmaceutical Manufacturing (Thailand) PCL's own PS Ratio has ranged from 0.76 to 17.58 over the past decade. While the company's 10-year median is 1.94 vs. the industry median of 0.85, JSP Pharmaceutical Manufacturing (Thailand) PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Consumer Packaged Goods company?
The median PS Ratio among Consumer Packaged Goods companies is 0.85, based on 1,940 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JSP Pharmaceutical Manufacturing (Thailand) PCL's current PS Ratio of 0.84 is 1.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on JSP Pharmaceutical Manufacturing (Thailand) PCL and its competitors. For the Consumer Packaged Goods industry, the median PS Ratio is 0.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JSP Pharmaceutical Manufacturing (Thailand) PCL's current PS Ratio is 0.84, which is 57% below median its own 10-year median of 1.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JSP Pharmaceutical Manufacturing (Thailand) PCL stock overvalued right now?
Based on GuruFocus' analysis, JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿3.17, compared to a current price of ฿1.75 — trading 44.8% below its estimated fair value. The current PS Ratio is 0.84, which is 57% below median its 10-year median of 1.94 and 1.2% below the Consumer Packaged Goods industry median of 0.85. JSP Pharmaceutical Manufacturing (Thailand) PCL's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP), the current PS Ratio is 0.84 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) Overvalued in 2026?

Based on GuruFocus' analysis, JSP Pharmaceutical Manufacturing (Thailand) PCL stock appears to be undervalued. The current stock price of ฿1.75 is trading 44.8% below its estimated GF Value™ of ฿3.17. GuruFocus considers JSP Pharmaceutical Manufacturing (Thailand) PCL to be Significantly Undervalued.

Key valuation signals for BKK:JSP:

  • PS Ratio: 0.84 (57% below median its 10-year median of 1.94)
  • GF Value™: ฿3.17 vs. price of ฿1.75 (44.8% below fair value)
  • GF Score™: 82/100 with 5 warning signs
  • Industry Position: 1.2% below the Consumer Packaged Goods median (#952 of 1940)

No single metric tells the full story. See the BKK:JSP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


JSP Pharmaceutical Manufacturing (Thailand) PCL Business Description

Address No. 255, 257 Soi Sathupradit 58, Bang Pongphang, Yan Nawa, Bangkok, THA, 10120
JSP Pharmaceutical Manufacturing (Thailand) PCL is engaged in producing modern medicine, traditional medicine, herbal products, dietary supplements, medical supplies, and cleaning alcohol under the client's and the company's own trademarks. Maximum revenue for the company is generated from the sale of dietary supplements. The Group's reportable operating segments are: Manufacture and distribution of products under the company's brand name (Own brands), which generate maximum revenue, Manufacture and distribution of products under customers' brand name (OEM), Manufacture and distribution of hemodialysis solution and related medical supplies; and Service, research and development, and healthcare products training. Geographically, it operates principally in Thailand.
82GF Score

Get the complete analysis for BKK:JSP

PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿1.75
Price
฿3.17
GF Value